KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Dynavax Technologies (DVAX) over the last 17 years, with Sep 2025 value amounting to $946.5 million.

  • Dynavax Technologies' Liabilities and Shareholders Equity fell 10.87% to $946.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year decrease of 6.52%. This contributed to the annual value of $986.3 million for FY2024, which is 1.09% down from last year.
  • Dynavax Technologies' Liabilities and Shareholders Equity amounted to $946.5 million in Q3 2025, which was up 3.05% from $918.4 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Liabilities and Shareholders Equity high stood at $1.1 billion for Q3 2024, and its period low was $490.1 million during Q1 2021.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $972.9 million (2023), whereas its average is $976.2 million.
  • In the last 5 years, Dynavax Technologies' Liabilities and Shareholders Equity skyrocketed by 194.18% in 2021 and then declined by 10.87% in 2025.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Liabilities and Shareholders Equity stood at $1.0 billion in 2021, then declined by 5.14% to $985.9 million in 2022, then grew by 1.14% to $997.1 million in 2023, then decreased by 1.09% to $986.3 million in 2024, then dropped by 10.87% to $946.5 million in 2025.
  • Its last three reported values are $946.5 million in Q3 2025, $918.4 million for Q2 2025, and $945.9 million during Q1 2025.